Coca-Cola's India Bottling Arm May File DRHP This Week, Eyes $10 Billion Valuation

Coca-Cola's Indian bottling business, Hindustan Coca-Cola Holdings (HCCH), is reportedly preparing to file its DRHP with SEBI by October 29, 2026. According to reports, the IPO could be worth approximately $1 billion (~₹9,500 crore), with the business targeting a valuation of around $10 billion. The listing is expected in 2027, subject to regulatory approvals and market conditions.

While the proposed valuation has attracted attention, investors need to understand what is actually being listed, how the business makes money, and whether its earnings can justify the reported valuation.

What Is Actually Listing?

This is the question that matters most. The company going public is not The Coca-Cola Company. It is HCCH, the parent of HCCB, the bottler behind Coca-Cola products in India. Investors would own a piece of the Indian bottling and distribution business, not the global brand owner.

The split of roles works like this:

• The Coca-Cola Company owns the brands and, under its bottling system, supplies beverage concentrates and related products to bottling partners. Its broader strategy includes shifting more bottling operations to independent partners so it can focus on brands and concentrate supply.
• HCCB manufactures, bottles, and distributes beverages to retailers. Established in 1997, it operates 14 bottling plants and handles brands such as Coca-Cola, Thums Up, Sprite and Fanta.

So the bottler earns from volumes, pricing and how efficiently it runs plants and trucks, not from owning the brand. The exact terms of its brand and concentrate arrangements should be examined in the DRHP.

The Deal Structure: Where Will the IPO Money Go?

Who owns what today: Coca-Cola holds 60% of HCCH, while Jubilant Bhartia Group owns the remaining 40%, following its ₹11,704.40 crore acquisition completed in July 2025.

Why is the IPO expected to be mainly an OFS? In an Offer for Sale (OFS), existing shareholders sell their shares and receive the proceeds. A fresh issue, by contrast, raises new capital for the company. Media reports suggest the IPO will primarily be a stake sale, and Coca-Cola has confirmed its intention to sell part of its holding. The DRHP will clarify the final structure and which shareholders are selling.

Why list now? The listing could allow Coca-Cola to monetise part of its investment in HCCH while giving existing shareholders a route to sell shares to public investors. It also fits the company’s broader refranchising strategy of moving bottling operations to independent partners. The precise rationale and extent of the stake sale will become clearer from the DRHP.

The Elephant in the Room (Valuation Gap)

One of the most important questions is how the proposed valuation compares with the private transaction through which Jubilant Bhartia Group acquired its 40% stake.

Jubilant announced the completion of the acquisition in July 2025. Its reported final consideration was ₹11,704.40 crore for 40% of HCCH. On a simple proportional basis, that implies an equity value of approximately ₹29,261 crore for the entire company at the transaction terms.

Sources: Jubilant Bhartia Group and Fortune India. The figures are not directly comparable without accounting for exchange rates, transaction terms, changes in the business and the valuation basis.

The apparent gap raises an important question: What has changed in the business to support the proposed valuation?

The valuation gap alone doesn't tell the full story. Investors need to assess the company's profitability, growth prospects, cash generation, and how its changing business footprint affects future earnings.

The Peer Benchmark (The Varun Beverages Factor)

Although the proposed IPO is of HCCH, its operating business, HCCB, can be compared with Varun Beverages (VBL), PepsiCo’s listed bottling partner in India. VBL offers a useful benchmark for how markets value a beverage bottling business.

Source: screener.in

VBL’s profit was roughly 14% of sales, compared with about 6% for HCCB in FY25, a notably weak year. VBL shows that public markets can reward a bottler that scales efficiently. If HCCB can deliver comparable distribution strength and margins, its valuation may be easier to justify. Until its FY26 financials are public, that remains uncertain.

Competition is another risk. Reliance’s Campa reportedly crossed ₹4,700 crore in gross sales in FY26, becoming India’s fourth-largest carbonated soft-drink brand by March 2026. Industry reports also indicate that smaller players gained market share, prompting Coca-Cola and PepsiCo to introduce ₹10 packs. Such price competition can put pressure on margins.

Final Take

The brand is iconic, but a famous name is not a reason to apply. This is a bottling business; the issue is reported to be mainly a stake sale, the valuation target is far above the last private deal, and the latest reported profit fell sharply.

A sensible approach is to wait for the DRHP to appear on SEBI’s website and read three things: restated net profit, EBITDA margins, and the split between fresh issue and OFS. Once the price band is announced, they can evaluate the valuation multiples and decide whether the business justifies the asking price.